Tg(Myh6-TFRC/OVA)#Ahlm
Transgene Detail
|
Symbol: |
Tg(Myh6-TFRC/OVA)#Ahlm |
Name: |
transgene insertion, Andrew H Lichtman |
MGI ID: |
MGI:6192766 |
Synonyms: |
cMy-mOVA |
Transgene: |
Tg(Myh6-TFRC/OVA)#Ahlm Location: unknown
|
Alliance: |
Tg(Myh6-TFRC/OVA)#Ahlm page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Myh6-TFRC/OVA)#Ahlm expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
TFRC (7037) |
|
mouse promoter and N-terminal fragment of human gene fused to part of chicken ovalbumin |
|
|
|
Mutation details: The transgene comprises the following elements: the mouse cardiac myosin heavy chain promoter, DNA sequence coding for amino-acids 2-118 of the human transferrin receptor (includes transmembrane sequence), DNA sequence coding for amino-acids 139-387 of the chicken ovalbumin gene, and, from the pcDNA3.1V5-His6-TOPO plasmid, V5 epitope sequence, His6 tag sequence, stop codon, and bovine growth hormone polyA signal. RT-PCR, ELISA and immunofluorescence experiments confirmed exclusive expression in myocardium. The construct was microinjected into embryonic stem cells. Mice carying this transgene will express a membrane-bound chimeric protein with the ovalbumin peptide exposed extracellularly. The ovalbumin peptide includes the two sequences that are recognised by the T cell receptors expressed by transgenes Tg(TcraTcrb)1100Mjb (OT-I) and Tg(TcraTcrb)425Cbn (OT-II) respectively.
(J:132693)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:132693 Grabie N, et al., IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest. 2003 Mar;111(5):671-80 |
All: |
3 reference(s) |
|